DEEPER-Seq Target Capture Kits

DEEPER-Capture™ Kits using
Double-stranded RNA Probes

Targeted sequencing has been an essential application in Next Generation Sequencing (NGS). However, all target capture commercial technologies on the market have relatively low capturing efficiencies. That being said, after utilizing those capture kits, instead of sequencing a sufficient number of unique molecules, you are actually sequecing a library of nucleic acid amplicons that are amplified from very few DNA molecules captured by those old commercial technologies from initial NGS library, and usually the fraction of molecules that can be captured and subsequently sequenced is less than 9% of the molecules from the initial NGS library. Due to the unsatisfying performance of current commercial capture kits and platforms, Omics Technologies has been trying to develop its own target capture technologies, and finally we have something to show you. We believe that this new technology could potentially revolutionize NGS targeted sequencing field.

We are proud to anounce DEEPER-Capture, the next generation target capture technology for NGS sequencing. In DEEPER-Capture both DNA strands from the same DNA duplex molecule are captured by a pair of complementary RNA probes, and sequenced, simutanously. Using DEEPER-Capture, we repeatedly achieved an over 3-fold higher capturing efficiency than the best performance ever observed from competing platforms reported by numerous labs (References 1~11).

There are several widely used commercial kits designed to capture subgenomic DNA regions for targeted NGS sequencing. Here is a table comparing the DEEPER-Capture with other competing technologies:

For further technical details and an in-depth discussion about why DEEPER-Capture can achieve such a fundamental improvement over other DNA (single or double stranded probes) or RNA-probe based platforms, please refer to the publication at http://rdcu.be/tqGw

*Patent Pending for DEEPER-Seq (including DEEPER-Library and DEEPER-Capture) technologies.

References:

1. Chilamakuri, C. S. et al. Performance comparison of four exome capture systems for deep sequencing. BMC Genomics 15, 449, doi: 10.1186/1471-2164-15-449 (2014).
2. Chung, J. et al. The minimal amount of starting DNA for Agilent’s hybrid capture-based targeted massively parallel sequencing. Sci Rep 6, 26732, doi: 10.1038/srep26732 (2016).
3. Clark, M. J. et al. Performance comparison of exome DNA sequencing technologies. Nat Biotechnol 29, 908–914, doi: 10.1038/nbt.1975 (2011).
4. Sulonen, A. M. et al. Comparison of solution-based exome capture methods for next generation sequencing. Genome Biol 12, R94, doi: 10.1186/gb-2011-12-9-r94 (2011).
5. Van Allen, E. M. et al. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat Med 20, 682–688, doi: 10.1038/nm.3559 (2014).
6. Albert, T. J. et al. Direct selection of human genomic loci by microarray hybridization. Nat Methods 4, 903–905, doi: 10.1038/nmeth1111 (2007).
7. Hodges, E. et al. Hybrid selection of discrete genomic intervals on custom-designed microarrays for massively parallel sequencing. Nat Protoc 4, 960–974, doi: 10.1038/nprot.2009.68 (2009).
8. Hodges, E. et al. Genome-wide in situ exon capture for selective resequencing. Nat Genet 39, 1522–1527, doi: 10.1038/ng.2007.42 (2007).
9. Ng, S. B. et al. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 42, 30–35, doi: 10.1038/ng.499 (2010).
10. Ng, S. B. et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 461, 272–276, doi: 10.1038/nature08250 (2009).
11. Okou, D. T. et al. Microarray-based genomic selection for high-throughput resequencing. Nat Methods 4, 907–909, doi: 10.1038/nmeth1109 (2007).

A dramatic improvement in capture efficiency by DEEPER-Capture can:

1) Significantly improve the sequecing efficiency by increasing the unique read counts in your NGS data. A great capture efficiency offered by DEEPER-Capture will eliminate excessive post-capture PCR amplification before NGS sequencing. Therefore, it dramatically reduces unwanted NGS sequencing on the redundant amplicons originally coming from the same sequence, increases the true coverage by unique reads, makes NGS more efficient, and significantly improve the NGS data quality.

2) Enable error-correction by capturing and sequencing two DNA strands from the same molecule together. DEEPER-Capture brings the traditional duplex sequencing of both DNA strands to the next level that you could directly capture both DNA strands and sequence them together.

3) Tackle the problems in clincial applications of NGS. In clinical NGS applications, the diseased samples can be highly heterogeneous and blended with normal tissues, thus making the true disease-causing sequence variants present at very low allelic fraction. DEEPER-Capture, with its ultra-high capture efficiency, will help you detect a rare mutation down to 0.03% allelic fraction on a whole exome sequencing scale, breaking the limitations of predefined subgenomic regions which all other ultra-rare mutation detection technologies are all restrained to.

We are releasing the DEEPER-Exome™- a DEEPER-Capture kit for targeted capture of human whole exome sequences (based on hg19 human genome reference database) for NGS purposes.

DEEPER-Exome™ kits include sufficient reagents for the generation of 16, 32 or 64 NGS libraries and required buffers for DEEPER-Capture based ultra-high efficiency target enrichment procedures. Optimized RNA probes (baits) targeting both DNA strands of the target sequences ARE INCLUDED in the kit. The kit provides you EVERYTHING (excluding necessary instrumentations) you need for your targeted capture NGS sequencing experiments. No separate purchase for baits is needed.